Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | AMGN | BMY | GILD | VRTX |
| Company | Aslan Pharmaceuticals Ltd ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.6300 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 0.7000 | 264.80 | 57.39 | 92.75 | 394.99 |
| Low | 0.6000 | 261.79 | 56.98 | 91.91 | 391.00 |
| Last | 0.6000 | 263.17 | 57.11 | 92.26 | 395.72 |
| Change | -0.0999 | -0.21 | -0.22 | -0.31 | -1.55 |
| % Change | -14.27% | -0.08% | -0.38% | -0.33% | -0.39% |
| Volume | 806,300 | 173,845 | 514,065 | 294,734 | 226,117 |
| 20-Day Average Volume | 289,117 | 5,016,514 | 11,468,113 | 7,379,836 | 1,768,751 |
| Previous Close | 0.6999 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0725 | 273.45 | 57.89 | 92.07 | 454.05 |
| 20-Day Raw Stochastic | 5.23% | 22.27% | 35.82% | 54.73% | 15.12% |
| 20-Day Relative Strength | 25.90% | 32.13% | 51.61% | 53.90% | 28.47% |
| Weighted Alpha | -93.79 | -15.22 | +18.49 | +22.78 | -12.66 |
| Today's Opinion | 100% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -75.71% since 07/11/24 | -1.27% since 12/16/24 | +2.13% since 12/16/24 | +0.12% since 12/16/24 | -16.09% since 12/16/24 |
| Low | 0.4750 on 07/17/24 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 2.7314 on 07/12/24 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -75.97% since 06/18/24 | -10.67% since 11/22/24 | -3.07% since 11/22/24 | +2.18% since 11/22/24 | -12.91% since 11/22/24 |
| Low | 0.4750 on 07/17/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 2.8640 on 06/21/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -86.11% since 04/18/24 | -21.60% since 09/23/24 | +14.10% since 09/23/24 | +9.73% since 09/23/24 | -14.62% since 09/23/24 |
| Low | 0.4750 on 07/17/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 4.8968 on 04/22/24 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -85.84% since 01/18/24 | -14.62% since 06/21/24 | +36.08% since 06/21/24 | +30.41% since 06/21/24 | -16.20% since 06/21/24 |
| Low | 0.4750 on 07/17/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 16.7200 on 03/12/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,226 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 2,044 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 12,000,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -44,220,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -9,920,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.40 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -10.32 on 05/09/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 08/09/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |